Sale of Securities

Cadrenal Therapeutics, Inc. Filed 2025-09-29 Acc 0001628280-25-043098

Documents 1

2025-10-01 144 Sale of Securities
2025-10-01 4 Chief Financial Officer sold 1,800 shares at an average $13.99 ($25,183)
2025-10-01 4 CEO and Chairman sold 1,300 shares at $14.01 ($18,213)
2025-09-29 144 Sale of Securities
2025-09-29 144 Sale of Securities
2025-09-29 144/A Sale of Securities
2025-08-27 144/A Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…